Table III.
Tissue | Post-injection (h) | Control | LPS | Poly I:C |
---|---|---|---|---|
Liver | 0 | 3.85±0.46 | 3.70±0.73 | 1.54±0.61 |
3 | 1.55±0.82 | 41.31±8.18 | 96.13±38.07 | |
6 | 2.34±1.37 | 20.78±4.11 | 27.58±10.92 | |
12 | 2.20±0.94 | 12.35±2.45 | 20.00±7.92 | |
24 | 2.08±1.20 | 3.50±0.69 | 15.90±6.30 | |
48 | 2.78±1.37 | 12.70±2.51 | 14.71±5.82 | |
72 | 3.31±1.18 | 2.50±0.49 | 6.80±2.69 | |
Spleen | 0 | 22.14±4.07 | 23.19±4.26 | 22.03±4.05 |
3 | 24.67±9.07 | 583.57±107.29 | 51.98±9.57 | |
6 | 19.13±7.03 | 99.59±18.31 | 76.12±13.99 | |
12 | 24.06±8.84 | 33.45±6.15 | 572.65±105.28 | |
24 | 21.33±7.83 | 25.27±4.64 | 78.10±14.36 | |
48 | 22.18±8.15 | 21.56±3.96 | 25.38±4.66 | |
72 | 23.00±8.46 | 19.05±3.50 | 22.28±4.11 | |
Kidney | 0 | 1.51±0.39 | 1.25±0.32 | 1.29±0.34 |
3 | 2.15±0.56 | 46.75±12.16 | 39.42±10.25 | |
6 | 2.38±0.62 | 31.20±8.11 | 3.96±1.03 | |
12 | 3.14±0.82 | 2.70±0.70 | 2.58±0.67 | |
24 | 2.15±0.56 | 2.40±0.62 | 2.97±0.77 | |
48 | 2.17±0.57 | 2.40±0.62 | 3.51±0.91 | |
72 | 3.02±0.79 | 2.30±0.60 | 3.66±0.95 | |
Intestine | 0 | 5.36±1.39 | 5.55±1.44 | 6.56±1.71 |
3 | 4.37±1.13 | 111.65±29.03 | 65.25±16.97 | |
6 | 5.15±1.34 | 5.32±1.38 | 101.25±26.33 | |
12 | 4.57±1.19 | 5.98±1.55 | 7.21±1.87 | |
24 | 5.32±1.38 | 5.90±1.53 | 6.90±1.79 | |
48 | 5.53±1.44 | 5.65±1.47 | 7.65±1.99 | |
72 | 5.52±1.44 | 6.87±1.79 | 7.32±1.90 |
Data are presented as the mean ± standard deviation. LPS, lipopoly-saccharide; poly I:C, polyinosinic:polycytidylic acid.